An Epidemiological Study of Diabetic Cataract in Scotland based on Electronic Health Record (GoDARTS dataset) by Chang, Cheng
University of Dundee
MASTER OF SCIENCE
An Epidemiological Study of Diabetic Cataract in Scotland based on Electronic Health
Record (GoDARTS dataset)
Chang, Cheng
Award date:
2016
Awarding institution:
University of Dundee
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 06. Mar. 2017
1 
 
Table of Contents 
Declaration ....................................................................................................................... 3 
List of Figures and Tables .............................................................................................. 4 
List of Acronyms ............................................................................................................. 6 
Abstract ............................................................................................................................. 7 
Introduction ...................................................................................................................... 9 
1. Understanding of Cataract from Epidemiology and Public Health Perspective .. 9 
2. Understanding of Cataract and Diabetic Cataract ................................................. 10 
2.1 Definition and Classification of Cataract ............................................................... 10 
2.2 Mechanism(pathogenesis) of Cataract and Diabetic Cataract........................ 11 
3. Prevalence of Cataract in Epidemiology Studies ..................................................... 12 
3.1 North America, Europe ................................................................................................ 13 
3.2 Developing Countries .................................................................................................... 14 
4. Risk Factors of Cataract .............................................................................................. 15 
5. Impact of Cataract and Other Visual Impairments ................................................ 18 
5.1 Individual Impact .......................................................................................................... 18 
5.2 Economic Impact............................................................................................................ 20 
6. Prevention, treatment and current state in health care system for cataract in UK
 25 
Objectives........................................................................................................................ 27 
Methods ........................................................................................................................... 28 
1. Introduction of Genetics of Diabetes and Audit Research Tayside Study 
(GoDARTS) ............................................................................................................................. 28 
2. Literature research ....................................................................................................... 29 
3. Data Collection and Handling ..................................................................................... 29 
4. Statistical Analysis ........................................................................................................ 32 
Result ............................................................................................................................... 33 
1. Demographic Characteristics of Studied Participants ............................................ 33 
1.1. Age ...................................................................................................................................... 33 
1.2. Gender ............................................................................................................................... 36 
1.3. Diabetes Type and History .......................................................................................... 37 
2 
 
1.4. Smoking ............................................................................................................................. 39 
1.5. Body Figure ...................................................................................................................... 39 
1.6. Deprivation Level ........................................................................................................... 40 
1.7. Summary of Demographic Characteristics ........................................................... 41 
2. Medical and Biochemical Tests ................................................................................... 43 
3. Summary of Baseline Characteristics for Any Cataract Group and 
Non-Cataract Group.............................................................................................................. 44 
4. Results on Cataract Prevalence .................................................................................. 47 
4.1. Prevalence of Diabetic Cataract and Age-adjusted Prevalence ...................... 47 
4.2. Prevalence of Diabetic Cataract by Different Subgroups ................................. 48 
4.2.1. Diabetic Cataract Prevalence by Gender ............................................................... 48 
4.2.2. Diabetic Cataract Prevalence by Age Group ........................................................ 49 
4.2.3. Diabetic Cataract Prevalence by BMI (Overweight) ......................................... 50 
4.2.4. Diabetic Cataract Prevalence by Diabetes Duration .......................................... 52 
4.2.5. Diabetic Cataract Prevalence by Smoking Status ............................................... 53 
4.2.6. Diabetic Cataract Prevalence by Deprivation Level .......................................... 54 
5. Identification and Exploration of Diabetic Cataract Risk Factors ....................... 55 
6. Comparison of Risk Factors for Any Cataract in Gender and Diabetes Duration 
Subgroups ................................................................................................................................ 60 
7. Result on Postcode areas .............................................................................................. 62 
7.1. Geographical Distribution of Diabetic Cataract Cases ..................................... 62 
7.2. Diabetic Cases Percentage in Each Postcode Area ............................................. 63 
7.3. Result for Dundee City Areas .................................................................................... 64 
8. Geographical Distribution of Diabetic Cataract Cases ........................................... 66 
Discussion........................................................................................................................ 68 
1. Discussion of the result ................................................................................................. 68 
2. Contribution of the study............................................................................................. 72 
3. Shortcoming and limitation ......................................................................................... 72 
Reference ........................................................................................................................ 74 
 
 
 
 
 
 
3 
 
 
Declaration 
 
I hereby declare that I am the author of this Thesis; that the work of which this thesis 
is a record has been done by me, and it has not previously been accepted for a higher 
degree. I also state that all references cited have been consulted by me personally and 
the conditions of the relevant ordinance and regulations have been fulfilled. 
 
 
 
 
Signed_________________________  Date__________________________ 
                                                         Cheng Chang 
 
 
 
 
 
Supervisor 
Signed__________________________ Date___________________________ 
                                                        Weihua Meng 
 
 
 
 
 
 
 
4 
 
 
List of Figures and Tables 
 
Figure 1. Pathophysiology of diabetic cataract formation--------------------------------12 
Figure 2. Process of any cataract group and non-cataract group (inclusion and 
exclusion) for analysis-------------------------------------------------------------------------31 
Figure 3. Distribution of participants by age group bar chart----------------------------34 
Figure 4. Q-Q plot of age----------------------------------------------------------------------34 
Figure 5. Distribution of participants by age group and gender bar chart--------------35 
Figure 6. Pie chart of gender------------------------------------------------------------------36 
Figure 7. Pie chart of cataract type-----------------------------------------------------------37 
Figure 8. The histogram of diabetes duration (years)--------------------------------------38 
Figure 9. Box plot of BMI by gender--------------------------------------------------------40 
Figure 10. Prevalence of diabetic cataract pie chart---------------------------------------47 
Figure 11. Prevalence of diabetic cataract in different gender bar chart----------------48 
Figure 12. Prevalence of cataract in different age groups bar chart---------------------50 
Figure 13. Prevalence of diabetic cataract by overweight or not bar chart-------------51 
Figure 14. Distribution of diabetic cataract by smoking status bar chart---------------53 
Figure 15. Distribution of diabetic cataract by deprivation level bar chart-------------54 
Figure 16. Geological distribution of diabetic cataract------------------------------------62 
Figure 17. Diabetic cases percentage in each postcode area------------------------------63 
Figure 18. Prevalence of diabetic cataract in Dundee postcode areas-------------------64 
Figure 19. Distribution of subjects’ deprivation level in Dundee postcode areas------65 
Figure 20. Pie chart of percentage for cataract eye and cataract extraction------------66 
Table 1. Risk factors for age related cataract-----------------------------------------------17 
Table 2. QOL dimensional structure, concept and impact on VI patients--------------19 
Table 3. Cost list of sight loss in UK in 2013-----------------------------------------------21 
Table 4. Health care system expenditure by country (2008 £ million) -----------------23 
5 
 
Table 5. Age group of all participants-------------------------------------------------------24 
Table 6. Age by gender------------------------------------------------------------------------35 
Table 7. Gender distribution------------------------------------------------------------------36 
Table 8. Duration of diabetes-----------------------------------------------------------------38 
Table 9. Smoking status-----------------------------------------------------------------------39 
Table 10. Body figures-------------------------------------------------------------------------39 
Table 11. Deprivation level distribution-----------------------------------------------------40 
Table 12. Summary of demographic characteristics---------------------------------------41 
Table 13. Characteristic of participants' medical and biochemical test results---------43 
Table 14. Summary of baseline characteristics for any cataract group and non-cataract 
group---------------------------------------------------------------------------------------------44 
Table 15. Prevalence of diabetic cataract---------------------------------------------------47 
Table 16. Cross-tabulation result for gender and cataract---------------------------------48 
Table 17. Cataract and age group------------------------------------------------------------49 
Table 18. Cataract prevalence by overweight status---------------------------------------50 
Table 19. Cross-tabulation result for duration of diabetes and cataract-----------------52 
Table 20. Cataract prevalence by smoking status------------------------------------------53 
Table 21. Cataract prevalence by deprivation level----------------------------------------54 
Table 22. Risk factors for any cataract in diabetic subjects-------------------------------55 
Table 23. Differences in the risk factors for any cataract---------------------------------61 
Table 24. Cataract related percentages------------------------------------------------------66 
Table 25. Missing and unknown cataract eye cases---------------------------------------67 
 
 
 
 
 
 
 
6 
 
List of Acronyms 
 
VI - Visual Impairment  
 
LOCS III - Lens Opacity Classification System III  
 
OCGS - Oxford Clinical Cataract Classification and Grading System 
 
AR - Araldose Reductase  
 
QOL - Quality of Life 
 
RCGP - Royal College of General Practitioners 
 
NHS - National Health Service 
 
GoDARTS - Genetics of Diabetes and Audit Research Tayside Study 
 
BMI - Body Mass Index 
 
SIMD - Scottish Index of Multiple Deprivation 
 
SBP - Systole Blood Pressure 
 
DBP - Diastole Blood Pressure  
 
LDL - Serum Low-density Lipoprotein 
 
HDL - Serum High-density Lipoprotein 
 
 
 
 
 
 
7 
 
Abstract 
 
Background 
As the leading cause of global blindness and visual impairment (VI) by World Health 
Organization in 2010, cataract has been becoming a substantial public health problem 
all over the world accounting for almost 40 million blind people in developed and 
developing countries. Cataract-related VI and other VI are becoming one of the 
biggest economic burdens in prevention and treatment. Among all risk factors for 
cataract, diabetes is one of the most significant ones and the population of diabetic 
patient is growing. There is few recent cataract epidemiology study which focus on 
diabetic population especially in developed countries.  
 
Aim 
To provide a brief report of prevalence of cataract in diabetic population and explore 
risk factors of diabetic cataract in a Scottish health board area. 
 
Method 
The data of 3279 diabetic subjects in this cross-sectional study were collected from 
The Genetics of Diabetes Audit and Research Tayside (GoDARTS) project. All data 
collected from participants are anonymously linked to their electronic health records 
with consent. Health records are from the Scottish Care Information-Diabetes 
Collaboration (SCI-DC) database and NHS database.  
 
Results 
The prevalence of diabetic cataract was 38.2% (95% confidence interval [CI], 
36.5-39.9), and the age adjusted prevalence was down to 24% (95% CI, 22.5-25.5). 
Prevalence was higher for women than men (40.8% vs. 36.0%, Relative Risk [RR] 
=1.13, 95% CI 1.04-1.24), and higher for those with shorter duration of diabetes (less 
than 10 years) than those with longer duration (49.7% vs. 37.5%, RR=1.33, 95% CI, 
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1.14-1.54). The risk factors for any cataract were older age (years, Odds Ratio [OR] 
=1.080, 95% CI, 1.070-1.090), longer duration of diabetes (years, OR=1.033, 95% CI, 
1.032-1.053), being in a richer family than the most deprived ones (OR, 1.306 for 
deprived group, 1.897 for middle, 1.718 for affluent group). For biochemistry factors, 
albuminuria ≥20 mg/L (OR=1.273, 95% CI, 1.077-1.504), higher serum low-density 
lipoprotein ([LDL], OR=1.440 for 2.03-2.50 mmol/L, OR=1.493 for >2.50 mmol/L). 
For protective factors, being a female (OR=0.816, 95% CI, 0.689-0.967), higher 
systole blood pressure (OR=0.991, 95% CI, 0.986-0.996), higher total serum 
cholesterol (OR=0.650 for 4.12-4.66 mmol/L, OR=0.624 for >4.66 mmol/L). 
 
Conclusions 
Nearly one fourth of the studied diabetic population had cataract, and there are neither 
evident risk factors nor protective factors for cataract in diabetic subjects that were 
inconsistent with factors for cataract in general population. 
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Introduction 
 
1. Understanding of Cataract from Epidemiology and Public Health Perspective 
 
The classic definition of public health is known as “the art and science of preventing 
disease, prolonging life and promoting health through the organized efforts of 
society”. 1 As time goes by, the meaning of public health has been broadened, the 
latest definition in terminology dictionary added “control of community infections, 
the education of the individual in principles of personal hygiene, the organization of 
medical and nursing service for the early diagnosis and preventive treatment of 
disease, and the development of the social machinery”. 2  
 
Visual impairment (VI) is one of the most concerned public health issues in the world 
and cataract is the second cause of visual impairment globally; also cataract accounts 
for more than half of world blindness. 3 Although most individual’s cataract are 
treated by surgery 4 but from public health practice perspective, more progress 
remains to be achieved. 
 
Epidemiology is the fundamental scientific method or tool in public health practice. It 
is the study of certain disease in a defined population. An epidemiological research on 
cataract can not only contribute to health guideline making, medical practice or policy 
decision by exploring the distribution, prevalence, determinants of cataract from 
population perspective, but also be used in evaluating and measuring the efficacy of 
cataract-related public health actions. But the roles of epidemiology in public health 
remain controversial after years of widely applications. The results of epidemiology 
can only offer scientific knowledge but the how to put those conclusions into public 
health actions is still a matter for our researchers to think.  
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Current studies of cataract in public health field still focus more on epidemiology. 
Those studies are mainly observational ones, which means that they analysis the data 
collected from a certain population or a representative subset without intervention. By 
all means, for now it is the best way to contribute data to the knowledge of current 
stats of cataract among populations. 
 
2. Understanding of Cataract and Diabetic Cataract 
 
2.1 Definition and Classification of Cataract 
 
Cataract is a visual impairment that causes opacity of the natural, crystalline lens of 
the eye due to opacification or optical dysfunction. It reduces the amount of incoming 
light and prevents a clear vision. 5,6 The definition of diabetic cataract is cataract that 
associated with diabetes mellitus. 
 
Most of cataract cases are age-related but there are other types of cataract: traumatic 
cataract is cataracts that occur after an eye injury; secondary cataract occurs after 
surgery for other kinds of eye disease, or develop along with other health problems, 
such as diabetes; 7,8 congenital cataract is cataract which babies born with or develop 
later during childhood; radiation cataract develops after radiation exposure. These 
different types of cataract are classified by etiologic or potential causation, but the 
causes of cataract are complicated, and the types of cataract coexist. Besides the 
etiological classification method, cataract can also be classified by the degree and 
anatomical location of clouding within the lens (morphological classification) by 
utilizing grading systems like Lens Opacity Classification System III (LOCS III) and 
Oxford Clinical Cataract Classification and Grading System (OCGS).  
 
For now, the most widely applied classification and grading method in epidemiology 
practice is Lens Opacity Classification System III, known as LOCS III. 9 It can 
distinguish the detailed type and density of the cataract by using slit-lamp and 
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retro-illumination pictures and comparing with standard photographic transparencies 
of lens of four types of cataract: nuclear color(NC), nuclear opalescence(NO), cortical 
cataract(C) and posterior subcapsular cataract(P). 10,11 
 
Another cataract grading method is the Oxford Clinical Cataract Classification and 
Grading System (OCGS). OCGS uses standard diagrams and Munsell color samples 
for the grading of nuclear cataract(NC), cortical cataract(C) and posterior subcapsular 
cataract(P). 
 
Nuclear cataract(NC), cortical cataract(C) and posterior subcapsular cataract(P) are 
the three primary type of age-related cataracts. The meaning of each type is 
self-explanatory by its name. Nuclear means that the cloudy areas are in the central 
portion of the lens; cortical indicates that cloudy areas exist in the lens cortex, which is 
the peripheral edge of the lens and posterior subcapsular means opaque area on the 
back surface of the lens beneath the lens capsule.  
 
2.2 Mechanism(pathogenesis) of Cataract and Diabetic Cataract 
 
Generally speaking, the key mechanism in cataract is oxidation injury (oxidative 
stress) caused by peroxide free radical that lead to changes in the crystallins in the 
lens. Protein and lipid in the lens that experiencing extensive oxidation can affect the 
refraction and transparency of the lens, thus increasing visual opacity. 12 
 
A review article suggests that increasing oxidative stress is strongly associated with 
both types of diabetes and can accelerate the development of diabetes complications 
including diabetic cataract. 13 But in acute diabetic cataract model oxidative stress 
plays only a minor role in the opacification of lenses while chronic oxidative stress 
caused by polyol pathway is an essential factor during the development of long term 
diabetic cataract and other diabetic complications. 14 
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The source of this oxidative stress was no longer unknown in the recent decade. The 
aldose reductase (AR) which catalyzes the reduction of glucose to sorbitol through the 
polyol pathway (AR pathway) is one of the most studied ones. 14,15 Osmotic stress is 
one of the hypothesis for diabetic cataract formation through AR pathway, suggesting 
that the intracellular increase of fluid in response to AR-mediated accumulation of 
polyols results in lens expansion and ultimately leading to cataract formation. 16-18 
 
 
Figure 1. Pathophysiology of diabetic cataract formation 
 
3. Prevalence of Cataract in Epidemiology Studies 
 
Globally, the number of individuals who are visually impaired is “estimated to be 285 
million, of whom 39 million are blind, with uncertainties of 10-20%”. 3 According to 
the latest report from WHO on visual impairment, cataract is the leading cause of 
blindness (51%) and the second leading cause of visual impairments (33%). It is 
estimated that the prevalence of cataract in adults over 50 years of age was estimated 
at 47.8% and approximately, 90% of global cataract are in developing countries. 19  
 
There are many classic large-scale cohort studies on cataract such as the Wisconsin 
Beaver Dam Study, the Australian Blue Mountains Eye Study, the Barbados Eye 
Study, the French Pathologies Oculaires Liees a I’s Age Study, and the West African 
Countries Study. 20-24 The current estimations of global cataract are mostly based on 
above studies.  
Glucose
Aldose Reductase 
(AR) pathway
Polyols(Sorbitol)
Retained within the lens
Osmotic Stress
Lens Swelling and 
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3.1 North America, Europe 
 
In a study conducted by The Diseases Prevalence Research Group in 2004, it is 
estimated that 20.5 million Americans older than 40 have cataract in either eye, and 
the prevalence of cataract in the US is 17.2%. The research group also provides an 
estimation of the total number of persons who may have cataract in the US by 2020. 
The predicted figure is 30.1 million. 25 
 
Another study in Canada provides the prevalence of visual impairment and blindness 
using WHO standard (39.9%). 26 According to another fact that there are one third of 
visual impairment and blindness are due to cataract and complicates, the crude 
prevalence of cataract in Canada is 13.1%. The author also states the prevalence 
estimates are “comparable to studies from Australia, the United States, and Europe” 
and the results are similar. 
 
For Europe, there is a informative review article covering major eye diseases, 
suggesting that the crude prevalence of cataract in European adults in 2007 was 
19.3%.27  
 
In an epidemiology study from Italy in 1994, the prevalence of cataract was estimated 
to be: nuclear opalescence in 18.5%, cortical cataract in 12.9%, and posterior 
subcapsular cataract in 10.8%. 28 The POLA study in France in 1998 provided the 
prevalence of cataract among men and women, 24.1%, 29%. 23  
 
In recent years, very few epidemiological studies have been conducted in the UK that 
has focused specifically on cataract, let alone cataract in the diabetic population. One 
study worth mentioning is the North London Eye Study. 29 This population based, 
cross-sectional study examined 1547 eligible people. The prevalence of cataract 
(senile or cataract within aged population) causing visual impairment was 30% among 
which, 88% of the participants were not be able to get in touch with necessary eye 
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services. Also in this population based, cross-sectional study, cataract prevalence for 
people aged 65 and older is 36%, and noticeably, there aren’t any similar 
observational studies based on GP registration record in recent decades. 
 
There are other studies that only focus on senile cataract. The crude prevalence of 
cataract in a Finish study is 34% in people over 65 years old and 10% in whole cases, 
which is relatively lower than other countries. 30 Similar figures are presented in a 
Polish study: 20.44% in people over 60 years old, 12.10% in all patients. 31 A Spanish 
study suggests that prevalence of senile cataract (over 64 years old) was higher in 
men (69.50%) in women (65.50%), but the different is statistically significant (P>0.05), 
the prevalence in this study is relatively higher than other countries. 32 
 
3.2 Developing Countries 
 
In a study focused on the exploring the prevalence of cataract for different types and 
in a Tanzanian population, the researcher included eligible individuals aged above 40 
years old (3268 cases) and graded the lens using WHO Simplified Cataract Grading 
System. The prevalence of cataract (grade 1 or above in either eye) was 15.6% for 
NSC, 8.8% for CC, and 1.9% for PSC. The prevalence of all types of cataract 
increased with age: 1.7% for NSC, 2.4% for CC, and 0.4% for PSC among persons in 
their 40s and 59.2% for NSC, 23.5% for CC, and 5.9% for PSC for those 70 years and 
older (P= 0.0001 for all cataract types). 33 
 
An epidemiology study in Beijing had a very detailed results presentation in its article. 
34 Among all 4439 subjects examined (all above 40 years old), the prevalence of 
nuclear cataract was 50.3% (95% CI: 48.8%–51.8%), and the overall prevalence of 
any cataract was 53.1% (95% CI: 51.6%–54.6%), increasing from 6.5% (95% CI: 
5.2%–7.8%) in those subjects 40 to 49 years of age to 52.3% (95% CI: 47.4%–55.3%) 
in those who were 50 to 59 years of age, and to 97.8% (95% CI: 96.4%–99.2%) in 
those 70 years and older (P<0.001). Frequencies of any cortical cataract and any 
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subcapsular posterior cataract were 10.3% (95% CI: 9.4%–11.3%) and 4.3% (95% CI: 
3.7%–4.9%), respectively. And in another study in Taiwan senile population (65 years 
old), the prevalence for any cataract was 59.2% (95% CI, 56.6%–61.8%). 35 
 
Another cross-sectional study in India randomly sampled people aged ≥60 years in 
villages in both north India and south India. The Age- and gender-standardized 
prevalence of cataract in studied population was 58% in north India (95% CI, 56%–
60%) and 53% (95% CI, 51%–55%) in south India (P=0.01).36 The prevalence for 
specific types of cataract were also calculated: The most common cataract was Nuclear 
cataract with the prevalence of 48% (95% CI, 46%–50%) in north India and 38% (95% 
CI, 37%–40%) in south India (P<0.0001) and figures for PSC were 21% and 17%; 
cortical cataract 7.6% and 10.2%. 36 
 
From above studies, it is worth noticing that cataract prevalence varies widely 
between studies from all over the world, the reasons for variation and difficulty for 
comparison among data could be the “differing population characteristics and 
diagnostic methods of lens opacity”. 37 
 
4. Risk Factors of Cataract 
 
Epidemiology studies on lens opacities focus mostly on age-related cataract, which 
means the population for these studies are mainly elder people. The reason is that age 
is the most distinct risk factor for cataracts, prevalence of any cataract or mixed 
cataract rises with elder age group. 23, 28, 30-37 In an evidence-based guideline for 
cataract surgery, the prevalence of cataract rose steadily with age: 16% in the 65 to 69 
years age group, 24% in people of 70 to 74 years of age, 42% in those 75 to 79 years 
of age, 59% in those 80 to 84 years and 71% in people of 85 years or more. 38 Yet 
there are other widely acknowledged risk factors that were widely studied. Older age, 
women gender, and family history are classified into unmodifiable risk factors. 6 In 
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epidemiology practice, we adjust age and gender factors so that other potential 
modifiable risk factors can be explored.  
 
According to an updated literature review, there are three main risk factors for senile 
cataract: smoking, UVB radiation exposure and diabetes mellitus. 19 These three 
factors have been frequently reported by multiple studies and reviews with adequate 
epidemiology and animal biochemistry evidence.  
 
For smoking, “evidence shows a causal relationship between cigarette smoking and 
cataract.” 39 It has been demonstrated by multiple studies that there was dose-effect 
relationship between pack of cigarette smoked and opacification degree and duration 
of smoking raised the risk of cataract. 40,41  
 
For UV-B light exposure, due to different exposure and outcome measurement, the 
relationship is not strong for all cataracts but only development of cortical cataract. 19 
In a review of 22 epidemiology studies, most of the epidemiologic evidence support 
that the UV-B light exposure is a causality factor for cortical cataract. 42 
 
Diabetes is one of the most significant risk factors for cataract and the population of 
diabetic patients is growing. There is an increased prevalence of cataract in diabetic 
subjects compared with non-diabetic individuals. 43 According to the International 
Diabetes Federation’s prediction, more than 285 million people have been affected by 
diabetes worldwide and this number is expected to reach 439 million by 2030. 44 In 
the famous Beaver Dam Study, result showed that diabetic patients were significantly 
“more likely to have cortical lens opacities” and were “more likely to have previous 
cataract surgery” than people without diabetes. Longer duration of diabetes also leads 
to a significant stronger probability of cataract. 20 Diabetes is also an important risk 
factor for other eye complications such as retinopathy, glaucoma. 45 
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Besides those three key factors, there are other risk factors gathered and categorized 
in Table 1. 
 
Table 1. Risk factors for age related cataract 
 Risk factor Higher risk/comment 
Basic character Age Older 
 Gender Woman 
 Race Unclear, controversial 
Personal condition Diabetes Longer duration 
 Obesity Higher BMI and wider 
waistline 
 Hypertension 
(Cardiovascular disease) 
 
 Diarrhea In some developing countries, 
controversial 
 Myopia Use of eyeglasses over 20 years 
Medical side effects Insulin  
 Corticosteroids  
 Cholesterol  
 Steroid  
 antioxidants Controversial 
Behavior  Smoking Longer time, more cigarette 
 Alcohol More intake 
Socioeconomic status Occupation Unprofessional  
 Education level Lower 
 Income Lower 
Environment Sunlight exposure Longer, less protection 
18 
 
5. Impact of Cataract and Other Visual Impairments 
 
5.1 Individual Impact 
 
For individuals with visual impairments, the main outcome measure of impact on 
their life is through quality of life (QOL) questionnaires. Many vision-related QOL 
questionnaires has been developed that can help evaluate the impact of cataract and 
other visual impairments on patients. There are also generic QOL questionnaires such 
as EuroQol questionnaire (EQ-5D) which covers much wider aspects, however, a 
recent study suggests that the grading of visual impairment was only significantly 
associated with the score from vision-related QOL, but not with general QOL score 
determined by the EQ-5D. 46 So a vision-related QOL questionnaire is preferable in 
the field of ophthalmology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
 
 
There are four key dimensions that are introduced to classify all QOL-related 
concepts: physical, functional, social, and psychological. 47 Following this 
dimensional structure, specific impacts on VI patients are listed in Table 2. 
 
 
 
 
 
 
Table 2. QOL dimensional structure, concept and impact on VI patients 
Dimensions 
of QOL 
Concept, meaning Specific impact 
Physical Symptoms, treatment 
Overall, eyesight, pain or discomfort 
around eyes 
Functional 
Self-care, mobility, activity level 
and activities of daily living 
Reading difficulty（paper, street sign）, 
hard to find things, poor mobility in dim 
light or at night, driving difficulty 
Social 
Social contact, interpersonal 
relationships 
Difficult to visit friends and going out 
have fun, influence working，hard to 
recognize people, accomplish less, 
financial pressure 
Psychological 
Cognitive function, emotional 
status, well-being, satisfaction 
and happiness 
Feel need a lot of help and rely too much 
on others, depression, anxiety, 
embarrassment, frustration, worry, low 
self-confidence 
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5.2 Economic Impact 
 
On one hand, cataract may bring about varied negative effects on patients’ individual 
lives; on the other hand, cataract can have influence on society, especially on 
economy. Additionally, previous studies have proved that cataract-related and other 
VIs are some of the biggest economic burdens in prevention and treatment. In India, a 
study of direct and indirect economic loss due to blindness was carried out to estimate 
the burden of diseases and the benefit from interventions for prevention and treatment 
of blindness. The result showed the total cost was approximately Rs. 5.3 billion 
($0.15 billion USD in the year 1996) for treating all cataract-related cases in India. 48 
Another study on the economic burden of adult visual disorder in the United States 
found that the total direct medical cost in 2004 was $6.8 billion. 49 And recently, the 
global cost of VI (including VI caused by cataract) which consist of direct costs, 
indirect costs and health burden was estimated to be about $3 trillion USD in 2010 
and was predicted to increase by 20% by 2020.50 
 
An Australian study in 2006 provided a detailed report on economic impact and cost 
of visual impairment in Australia. 51 In 2004, visual impairments cost Australia about 
A$9.85 billion (approximately £5.24 billion), A$1.8 billion was spent on direct health 
system. The cost of VI is the seventh among all health system costs, ahead of VI is 
coronary heart disease, diabetes, depression, and stroke. Notably, cataract takes the 
largest 18% part of whole expenditure.  
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Table 3. Cost list of sight loss in UK in 2013  
Cost type Result 
Healthcare costs – Total direct NHS expenditure on eye health £2.64 billion 
Primary care costs – Expenditure on providing primary eye care 
services, which includes NHS sight tests 
£496 million 
Inpatient costs – Expenditure on providing inpatient ophthalmology 
services 
£536 million 
Outpatient costs – Expenditure on providing outpatient ophthalmology 
services 
£677 million 
Cost of care – Cost of providing residential and community care to 
blind and partially sighted people 
£370 million 
Indirect costs – Total cost of unpaid care, reduced employment and 
other indirect costs to the UK economy as a result of sight loss 
£5.3 billion 
 
 
Table 3 is a factsheet about sight loss in UK provided a detailed list of cost in 2013. 52 
 
In the above table, except indirect costs, other costs combined are called direct costs. 
In 2013, UK spent about £12.1 billion on eye-related cares and services, NHS 
expenditure alone accounts for 21.8% of total cost. 52 The corresponding percentage 
for Australia healthcare system is roughly 18.2%. In this report, Direct NHS expense 
includes hospital care (inpatient admissions, outpatient appointments); eye relevant 
medications and prescriptions; and some NHS sight tests, and for primary care 
services, most of the money goes to NHS sight tests provision. 
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The indirect cost of blindness and visual impairments is estimated to be about £5.3 
billion, an increase of over £200 million compared to estimates for 2012. The largest 
proportion of indirect costs is associated with informal care, which in most cases is 
unpaid care or support from family members, friends or neighbors. Higher 
unemployment rates and the cost of extra medications and equipment are also 
significant contributors in indirect costs. All those costs combined put a huge 
economic burden on society. 
 
Another report gives detailed cost figure of UK health care system expenditure by 
county and by eye condition in the year 2008. 53 (Table 4, Table 5) Expenditure on 
cataract can’t be calculated because some costs are lack of information. But the rough 
estimation of cost on cataract is over 470 million (adding up all known figure), it is 
over 22% of total cost, similar to the 2013 report. 
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Table 4. Health care system expenditure by country (2008 £ million) 
  England Scotland Wales N.I. Total 
Hospital recurrent 
expenditure  
490.69 57.1 31.59 13.34 592.74 
Non-admitted 
expenditure  
437.46 31.68 26.77 12.08 507.99 
Prescribing 
expenditure  
134.9 10.78 9.37 3.09 158.12 
General ophthalmic 
services (GOS)  
386.28 56.93 24.44 16.39 484.04 
Expenditure associated 
with injurious falls  
N N N N 25.1 
Research and 
development  
N N N N 13.99 
Residential care and 
community care 
services  
242.42 37.4 13.16 11.71 304.69 
Capital and 
administration  
N N N N 58.22 
Total 
    
2,144.89 
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Table 5. Health care system expenditure by eye condition (2008 £ million)  
 AMD Cataract DR GLCMA RE Other Total 
Hospital recurrent 
expenditure 
37.99 334.66 78.63 14.60 13.81 113.05 592.74 
Non-admitted 
expenditure 
15.56 82.48 245.34 19.75 55.13 89.75 507.99 
Prescribing 
expenditure 
3.42 29.29 5.21 109.66 0.77 9.79 158.12 
General ophthalmic 
Services (GOS) 
7.93 23.98 11.16 11.52 424.75 4.70 484.04 
Expenditure 
associated with 
injurious falls 
N N N N N N 25.10 
Research and 
development  
3.42 0.73 3.32 1.04 5.49 0.00 13.99 
Residential care and 
community care 
services  
N N N N N N 304.69 
Capital and 
administration 
N N N N N N 58.22 
Total       2,144.89 
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6. Prevention, treatment and current state in health care system for cataract in UK 
 
Currently, there is no proven intervention that can affectively prevent both the 
formation and progress of cataract. As mentioned in section 4, a lot of factors have 
been proven related with cataract. The incidence of senile cataract is associated with 
obesity but whether weight loss can effect on cataract or not remains to be studied. 
Similarly, smoking is one of the well-known risk factors of cataract, dose-effect on 
development of cataract has long been proven by multiple studies, but until now, the 
consequence of stopping smoking on cataract is still unknown. 
 
Oxidative stress is a major cause of cataract development, basic science research has 
demonstrated antioxidants had protective effect on lens tissue, and in several 
observational studies, vitamin C supplement can decrease risk of cataract formation. 
54 Some nutritional supplementation studies were carried out in the last decades 
suggesting that anti-oxidant vitamin supplements may prevent cataract. 55-58 Review 
of cataract prevention mentioned that there was one large interventional trial that 
“demonstrated a significant difference in participants treated with high-dose vitamin 
C versus placebo” while “a more recent interventional study did not replicate these 
findings”. 54  
 
However, according to the latest factsheet provided by Royal College of General 
Practitioners (GCGP), there are alternative approaches that may alleviate patients’ 
opacified vision who are not suitable for surgery or choose not to have. For example, 
avoiding direct exposure of sunlight by “wearing a hat, or/and sunglasses (with UV-B 
protection)” in sunny days; increasing brightness levels while reading; update to 
stronger lens. 
 
With all that said above, for now, most cataracts are considered as not preventable. 
The method to reduce cataracts significantly is through proper treatment and the only 
effective treatment for cataracts is extraction of opacified lens. Through surgery, 
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visually impaired or blind cataract patient can restore sight to as normal as possible. 
With years of improvement in cataract extraction technic, it has become low risk, high 
benefit and cost-effective. 59 
 
In UK, cataract extraction is the most frequently operated surgery and the number of 
cataract operations increased from 247,847 in 2001/2 to 336,967 in 2011/12. (HSCIC) 
It is performed mostly on elder group, over 90% of patients were 60 years or older. 
The access to surgery in UK with NHS is usually within a waiting time of less than 3 
months. In addition, geographic variations in cataract removal surgery rates is still 
evident 60 and a new concern is that over provision now have become an issue in 
certain areas in UK. 61,62 
 
Nowadays, microsurgical techniques and intra-ocular lens technology keeps getting 
better and more affordable, as a result, in the quality and accessibility of cataract 
extraction and post-operative rehabilitation has also continued to improve, thus, the 
growth of recommendations and demand for cataract surgery is inevitable and with 
increasing life expectancy, cases of cataract and the demand for surgery will likely to 
rise in the near future. 
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Objectives 
 
Cataract is the cause of blindness in 40 million people globally. Diabetes is one of the 
most significant risk factors and the population of diabetic patients is growing. Yet 
there are few recent cataract epidemiological studies which focus on a diabetic 
population especially in developed countries. UK is a developed country with a 
publicly funded health care system referred to as the National Health Service (NHS) 
which covers almost all medical and surgery needs for UK citizens including cataract. 
With the growing senile population and longer life expectancy, the need for cataract 
treatment and prevention will continuously rise which will ultimately add burden to 
NHS. 
 
With the benefit of electrical medical record combined with the database from the 
GoDARTS project, this epidemiological analysis became possible without any large 
scale questionnaire survey.  
 
The goal of this study is to provide an updated report of the demographic data and the 
prevalence of cataract in a diabetic population and explore risk factors of diabetic 
cataract in Tayside health board area. 
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Methods 
 
1. Introduction of Genetics of Diabetes and Audit Research Tayside Study 
(GoDARTS) 
 
GoDARTS stands for “Genetics of Diabetes and Audit Research Tayside Study”, this 
study is a quality resource that was initially funded by Wellcome Trust and supported 
by Diabetes UK. So far, there are three collections that consist of the GoDARTS 
database. All data in GoDARTS were collected from participants with consent. 
Patients gave informed consent to anonymously link their baseline data to their NHS 
electronic health records. The medical records include patient's prescribing history, 
general practice clinic visits, hospital admissions, and outpatient appointments. 
Furthermore, their personal information is anonymously linked with the Scottish Care 
Information-Diabetes Collaboration (SCI-DC) database. The consent also included 
anonymous retrospective and prospective follow up relating to diabetes from 
electronic medical records that were managed by the Health Informatics Centre (HIC) 
at the University of Dundee. 
 
The core collection is Genetics of Diabetes Audit and Research in Tayside, which is a 
pilot study from January 1997 to October 2004; the second collection is Wellcome 
Trust Type 2 Diabetes Case Control Collection (WTCCC) which added Type 2 
Diabetes case and control data into the database from October 2004-May 2009; and 
from October 2009, current collection continued to expand as WTCCC extension, the 
area covered are now including parts of Fife area.  
 
So far, the dataset has more than 9000 consented patients with type 2 diabetes and 
over 8000 non-diabetics matching controls. Original data used in my project was 
updated until 2011, which consist of a total number of 10416 cases including patients 
with all types of cataract. 
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2. Literature research 
 
The literature research consists of paper searching and reviewing which were for the 
purpose of background knowledge learning and information collecting. Because of 
the subject of this study belongs under one of the diabetic complications: cataract, my 
searching began with keywords as follows: cataract, visual impairment. Using these 
two core words combined with other keywords regarding to different aspects of my 
study was my overall searching strategy.  
 
Review articles about cataract were first collected by using keywords “cataract” and 
“review”, and the latest review papers and some of their reference articles were 
carefully studied in order to have a general understanding of cataract including 
definition, classification, characteristic, pathobiology, etc. Then there were 
epidemiology studies and reports about cataract on a scale of regions, countries and 
even worldwide gathered from keywords searching “epidemiology”, “report”, 
“prevalence”, “risk factor”, “cataract” and “visual impairment”, by sorting out these 
papers, I got to know the prevalence of cataract in different regions and some of the 
key risk factors worth noticing.  
 
Since the subjects in my dataset were all with diabetes condition, and my aim of this 
study is mainly to provide an updated report of cataract in a diabetic population and 
explore risk factors of diabetic cataract, articles concerning of diabetic cataract were 
separately searched with extra keywords: “diabetes”, “diabetic”, “diabetes mellitus” 
and “DM”. During this process, I found out that there has been no paper or report on 
diabetic cataract for the past two decades, which justified the rationality of my study. 
 
3. Data Collection and Handling 
 
Data were initially collected for my study in plain txt format. I imported all the data 
into SPSS so that all data files can be combined together with in one single file. Each 
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individual has a unique anonymous ID number, so that when combining two data files 
that included different aspects of patients e.g. biochemistry data, eye data, diabetes 
data, demographic data, blood pressure, deprivation and other miscellaneous data. 
Some of the raw data were calculated into new proper figures, such as duration of 
diabetes and BMI. The diabetes duration was a period from the date when a subject 
was first recorded or diagnosed with cataract till either the date the data was handled 
or the date the subject died before this study. A valid ID had to be presented in both 
files. If not, IDs and their representing case data shall be removed from collection.  
 
Firstly, I combined all data files (excluding cataract related data) without any 
exclusion, and 10416 cases were included in my original collection. In this dataset, 
participants with all types of cataract, all ages or even missing some of phenotypic 
data. Since this is epidemiology study, there is no need to merge genotype data into 
my dataset. 
 
The second step was to remove invalid cases with missing variables and/or outliner 
figures (e.g. age above 110 years) using the method above, cases with missing 
variables were excluded firstly in this step. From literature reviews about diabetes and 
cataract, I targeted people with the age of above 40 years with a history of Type 1 and 
Type 2 diabetes, and after removing all unqualified cases, a dataset of 7100 cases was 
created. 
 
And the last step was to merge cataract data into my 7100 cases dataset. Before 
combining, the definition of a cataract case and a non-cataract case was necessary, in 
this study, a diabetic cataract case was defined as a diabetic patient (including type 1 
and type 2 diabetes) who has had cataracts in at least one eye or cataract extraction 
surgery in at least one eye, according to linked e-health records. The subtype of 
cataract such as cortical, nuclear, posterior subcapsular cataract as well as the severity 
of cataract were not indicated in the e-health records, thus, the cataract case in the 
study referred to as any cataract case. The diagnosis of cataract was mainly made by 
31 
 
clinicians in the annual national retinal screen service. A non-cataract case was 
defined as a diabetic patient who has never been diagnosed with a cataract in the 
e-health records and has no cataract extraction surgery history. 
 
When combining cataract data with 7100 cases dataset, 3821 cases removed because 
of lack cataract-related data (cataract eye, surgery eye information) or cataract status 
unknown. Finally, a dataset with 3279 cases in Tayside population was ready for 
further statistical analysis. The whole process of the any cataract group and 
non-cataract group (inclusion and exclusion) for analysis was organized in Figure 2.  
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4. Statistical Analysis 
 
First, the prevalence of diabetic cataract was analysed and then the age-adjusted 
prevalence was calculated using adjusted age groups based on the Scotland Health 
Board Area 2006 census for the Tayside area. Prevalence for gender subgroups and 
duration of cataract subgroups (≤10 years and >10 years) were also analysed and 
compared using χ2 test, with P<0.05 indicating statistical significance. We then 
assessed baseline characteristics between the any cataract group and the non-cataract 
group by applying independent sample t-test for numerical variables and χ2 test for 
categorical variables. The risk factors for diabetic cataract were evaluated through 
both univariate analysis and multivariate analysis. Contingency tables were used for 
univariate analysis providing odds ratio (OR) for each risk factor with 95% CI. An is 
a measure of association between an exposure and an outcome. The OR represents the 
odds that an outcome will occur given a particular exposure, compared to the odds of 
the outcome occurring in the absence of that exposure. For multivariate analysis, 
based on the review of general cataract, all variables included in the binary logistic 
regression model were pre-selected using enter mothed. And the regression was used 
to estimate the adjusted OR and test the possible association of other variables with 
diabetic cataract. We judged P values of 0.05 or less to be significant. All data 
handling and analysis were preformed using SPSS version 20. Geography figures 
were generated using Arcmap 10.3. 
 
 
 
 
 
 
 
 
 
33 
 
Result 
 
1. Demographic Characteristics of Studied Participants 
 
There were 3279 diabetic participants included for analysis, with either type 1 or type 
2 diabetes and age above 40 years old. The mean age was 75.50 years with standard 
deviation of 11.23 years, the minimum age was 41 years and the maximum age was 
101 years. In addition, among 3279 subjects, 46.2% were woman and 53.8% were 
man. Type 1 diabetes is relatively rare in the studied population with the percentage 
of 7.4% (95%CI: 6.6%-8.3%) compared to the more common type 2 diabetes (92.6%, 
95%CI: 91.7%-93.5%). 
 
1.1. Age 
 
Table 5. Age group of all participants 
Age group 
(Excluding upper limit) 
Number of case Percentage 
40-50 years 76 2.3% 
50-60 years 230 7.0% 
60-70 years 610 18.6% 
70-80 years 1043 31.8% 
80-90 years 1046 31.9% 
90 years above 274 8.4% 
Total 3279 100.0% 
 
People with the age of 40 years and above were included in this study and the 
minimum age was 41, the maximum age was 101. People with the age of above 65 
years old were considered as senile individual with the percentage of 83.0%. 
Moreover, from the table and figure showing the age group distributions, it is clear 
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that the whole studied population was tend to be senile population. The most of the 
subjects were in the age group 80-90 years (1046, 31.9%) and the second most age 
group was 70-80 years (1043, 31.8%), followed with age group 60-70 years (610, 
18.6%), age group 90 years and above (274, 8.4%), age group 50-60 years (230, 7%) 
and age group 40-50 years (76, 2.3%). In the bar chart of age group, the distribution 
was negatively skewed but the Q-Q plot indicated that the age distribution could be 
approximated as normal distribution. Because of the negative skew of the age group 
distribution, median age was used instead of mean age. 
 
Figure 3. Distribution of participants by age group 
Figure 4. Q-Q plot of age 
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Figure 5. Distribution of participants by age group and gender 
 
 
For these 1516 women, the median age of female was 78 years old and 76 years old 
for male. The median age of female and male among the general population of 
Scotland is lower than the studied population according to the 2006 Scotland's Census 
data.  
 
 
 
 
 
Table 6: Age by gender 
Gender Number Median 1st Quartile 3rd Quartile Std. Deviation 
Woman 1516 78 69 85 11.70 
Man 1763 76 68 83 10.78 
Total 3279 77 69 84 11.23 
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1.2. Gender 
 
 
 
 
 
 
 
 
Figure 6. Pie chart of gender 
 
 
Among 3279 subjects, 1516 were woman and 1763 were man. Female subjects 
contributed 46.2% of the total cases while male subjects contributed 53.8%. More 
female than male was in my collection of data. 
 
 
 
 
 
Table 7. Gender distribution 
Gender Frequency Percentage 
Women 1516 46.2% 
Men 1763 53.8% 
Total 3279 100.0% 
1516
46.2%1763
53.8%
Women Men
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1.3. Diabetes Type and History 
 
Type 1 diabetes is relatively rare in the studied population with the percentage of 7.4% 
(95%CI: 6.6%-8.3%) compared to the more common type 2 diabetes (92.6%, 95%CI: 
91.7%-93.5%). 
 
Figure 7. Pie chart of cataract type 
 
And in terms of diabetes duration, the shortest diabetes history was 3 years and 
longest was 73 years, the mean duration of diabetes was 19.96 years with a standard 
deviation of 8.4 years. More than 90% percent of the included individuals had 
diabetes history of over 10 years while patients with diabetes of no more than ten 
years consisted of only 5.7% of the whole participants (Table 8). By looking into the 
frequency distribution of diabetes duration in Figure 8, I found that the histogram had 
a slight positive skew (skewness=1.56), the first quartile was 15 years, the second 
quartile was 18 years, and the third quartile was 27 years. 
 
 
 
243
7.4%
3036
92.6%
Type 1 Type 2
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Table 8. Duration of diabetes 
  Frequency Percentage 
Duration of diabetes, ≤10 years 187 5.7% 
Duration of diabetes, >10 years 3092 94.3% 
Total 3279 100.0% 
 
 
 
 
Figure 8. The histogram of diabetes duration (years) 
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1.4. Smoking 
 
Table 9. Smoking status 
Smoking status Number Percentage 
Unknown 2 0.1% 
Current smoker 448 13.7% 
Ex-smoker 1173 35.8% 
Non smoker 1656 50.5% 
Total 3279 100.0% 
 
Among 3279 subjects who had smoking status records, 448 (13.7%) were current 
smoker, 1173 (35.8%) were former smoker, 1656 (50.5%) never smoked. The length 
of smoking was not included in GoDARTS dataset. 
 
1.5. Body Figure 
 
The mean height of the population was 1.66 m, mean weight was 83.92 kg, and the 
body mass index (BMI) had the mean of 30.29 kg/m^2. If having BMI>25 kg/m^2 is 
defined as overweight, the prevalence for this particular population will be 80.2% 
(2631/3279). The gender difference can be observed from the box plot below (Figure 
9), in this box plot, both women and men had similar level of BMI between the first 
quartile and the third quartile. 
 
 
 
 
 
 
 
Table 10. Body figures 
  Mean Std. Deviation Minimum Maximum 
Height (m) 1.66 0.1 1.34 2.00 
Weight (kg) 83.92 19.75 34.90 191.80 
BMI (kg/m^2) 30.29 6.44 13.63 64.09 
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Figure 9. Box plot of BMI by gender 
 
1.6. Deprivation Level 
 
Deprivation Level in this study was defined using the SIMD (Scottish index of 
multiple deprivation) score which was based on the relative ranking from most 
deprived to least deprived. In this dataset, the relative ranking score was based in 
families within Tayside health board area. Deprivation level includes “most deprived”, 
“deprived”, “middle”, “affluent”, “most affluent” five levels. 
 
Table 11. Deprivation level distribution 
Deprivation level Frequency Percentage 
most deprived 1046 31.9% 
deprived 690 21.0% 
middle 451 13.8% 
affluent 444 13.5% 
most affluent 648 19.8% 
Total 3279 100.0% 
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In Table 11, it was worth mentioning that 31.9% of the participants were from most 
deprived families in Tayside health board area, and 21% were from deprived families, 
and these two combined consisted of more than half of the population. 
 
1.7. Summary of Demographic Characteristics 
 
Table 12. Summary of demographic characteristics 
  Frequency or Mean Percentage or SD 
Age group 
 
 
40-50 years 76 2.3% 
50-60 years 230 7.0% 
60-70 years 610 18.6% 
70-80 years 1043 31.8% 
80-90 years 1046 31.9% 
90 years above 274 8.4% 
Gender 
  Women 1516 46.2% 
Men 1763 53.8% 
Diabetes type 
  Type 1 diabetes 243 7.4% 
Type 2 diabetes 3036 92.6% 
Duration of diabetes 
  Duration of diabetes, ≤10 years 187 5.7% 
Duration of diabetes, >10 years 3092 94.3% 
Smoking status 
  
Unknown 2 0.1% 
Current smoker 448 13.7% 
Ex-smoker 1173 35.8% 
Non smoker 1656 50.5% 
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Body figures     
Height (m) 1.66 0.1 
Weight (kg) 83.92 19.75 
BMI (kg/m^2) 30.29 6.44 
Deprivation level (Tayside) 
  
Most deprived 1046 31.90% 
Deprived 690 21.00% 
Middle 451 13.80% 
Affluent 444 13.50% 
Most affluent 648 19.80% 
 
 
To sum up, the studied population was a senile, overweighed group, with more than 
half of the individuals below middle deprivation level and almost 95% percent of 
diabetic patients had long-term (over 10 years) diabetes. The collected data contains a 
wide range of participants with different social background and clinical features to 
explore diabetic cataract from demographic perspective. 
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2. Medical and Biochemical Tests 
 
Table 13. Characteristic of participants' medical and biochemical test results 
  Mean or N SD or % 95% CI 
Blood pressure 
   
  Diastole, mmHg 71.66 10.75 71.30-72.03 
  Systole, mmHg 136.71 18.78 136.07-137.36 
Biochemical tests 
   
  Total serum Cholesterol, mmol/L 3.97 0.98 3.94-4.00 
  Serum triglycerides, mmol/L 1.82 1.12 1.79-1.86 
  serum LDL cholesterol, mmol/L* 1.95 0.80 1.92-1.97 
  Serum HDL cholesterol, mmol/L* 1.28 0.41 1.27-1.29 
  HbA1c, mg% 7.74 1.59 7.68-7.79 
Albuminuria 
   
  <20 mg/L 2152 65.6% 64.0%-67.2% 
  ≥20 mg/L 1127 34.4% 32.8%-36.0% 
 
The diastole blood pressure (DBP) of the population was 71.66 mmHg±10.75 mmHg 
(95% CI: 71.30 mmHg -72.03 mmHg), which lay in the ideal DBP range (60 
mmHg-80 mmHg); the systole blood pressure (SBP) was 136 mmHg±18.78 mmHg 
(95% CI: 136.07 mmHg -137.36 mmHg) which was between the interval for pre-high 
blood pressure (120 mmHg -140 mmHg) 
 
The albuminuria test result showed 34.4% of diabetic patients had albuminuria more 
than 20 mg/L, which could indicate incipient diabetic kidney disease (more than 20 
mg/L less than 300 mg/L). 
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3. Summary of Baseline Characteristics for Any Cataract Group and Non-Cataract 
Group 
 
 
Table 14. Summary of baseline characteristics for any cataract group and non-cataract group  
 Non-Cataract (n=2026)  Any Cataract (n=1253)  
 n(%) or 
Mean ± SD 
95% CI  n(%) or 
Mean ± SD 
95% CI P 
Age, y 72.51±11.07 72.03-72.99  80.38±9.67 79.84-80.91 <0.0001 
Gender: Women 898(44.3) 42.2-46.5  618(49.3) 46.6-52.1 0.005 
Duration of diabetes, y 19.04±7.24 18.72-19.35  21.47±9.84 20.92-22.02 <0.0001 
Smoking      0.021 
  Non-smoker 1023(50.5) 48.3-52.7  633(50.5) 47.8-53.3  
  Ex-smoker 680(33.6) 31.5-35.6  493(39.3) 36.6-42.1  
  Current smoker 321(15.8) 14.3-17.4  127(10.1) 8.5-11.8  
BMI, kg/m2 30.84±6.54 30.55-31.12  29.40±6.18 29.06-29.75 <0.0001 
Deprivation Level (Tayside) 
** 
     <0.0001 
  Most deprived 727(35.9) 33.8-38.0  319(25.5) 23.0-27.9  
  Deprived 411(20.3) 18.5-22.0  279(22.3) 20.0-24.6  
  Middle 237(11.7) 10.3-13.1  214(17.1) 15.0-19.2  
  Affluent 241(11.9) 10.5-13.3  203(16.2) 14.2-18.2  
  Most affluent 410(20.2) 18.5-22.0  238(19.0) 16.8-21.2  
Blood pressure       
  Diastole, mmHg 72.60±10.54 72.14-73.06  70.16±10.92 69.55-70.76 0.017 
  Systole, mmHg 137.35±17.95 136.57-138.13  135.69±20.02 134.57-136.80 <0.0001 
Biochemical tests       
  Total serum Cholesterol, 
mmol/L 
4.02±0.98 3.97-4.06  3.89±0.96 3.84-3.95 <0.0001 
45 
 
  Serum triglycerides, mmol/L 1.88±1.15 1.83－1.93  1.74±1.05 1.68-1.79 0.001 
  serum LDL cholesterol, 
mmol/L* 
1.96±0.82 1.93-2.00  1.92±0.76 1.88-1.96 0.132 
  Serum HDL cholesterol, 
mmol/L* 
1.27±0.40 1.25-1.29  1.30±0.42 1.27-1.32 0.108 
  HbA1c, mg% 7.79±1.62 7.72-7.86  7.66±1.54 7.57-7.74 0.023 
Albuminuria      0.009 
  <20 mg/L 1386(68.4) 66.4-70.4  766(61.1) 58.4-63.8  
  ≥20 mg/L 640(31.6) 29.6-33.6  487(38.9) 36.2-41.6  
  
*Differences not statistically significant between no cataract and any cataract group (P≥0.05) 
**Deprivation Level (Tayside): the SIMD (Scottish index of multiple deprivation) score which was based on the relative 
ranking in Tayside from most deprived to least deprived. In this study, deprivation level includes “most deprived”, 
“deprived”, “middle”, “affluent”, “most affluent” five levels.  
 
 
Table 14 presents the baseline characteristics of the study population between 
non-cataract group (n=2,026) and any cataract group (n=1,253). Only serum 
low-density lipoprotein (LDL) cholesterol and serum high-density lipoprotein (HDL) 
cholesterol were not significantly different between the non-cataract and any cataract 
groups (P≥0.05).  
 
Compared to the non-cataract group, the any cataract group consisted of older 
participants (80.38 vs. 72.51 years), fewer female subjects (44.3% vs. 49.3%) and a 
longer history of diabetes condition (21.47 vs. 19.04 years).  
 
For smoking status, the percentage of non-smokers are identical between the two 
groups (50.5%) while the non-cataract group had fewer ex-smokers and more current 
smokers than the any cataract group (33.6% vs. 39.3%, 15.8% vs. 10.1%). 
Surprisingly, BMI and blood pressure were higher for non-cataract group (BMI: 30.84 
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vs. 29.40 kg/m^2, diastolic blood pressure: 72.60 vs. 70.16 mmHg, and systolic blood 
pressure: 137.35 vs. 135.69 mmHg).  
 
For deprivation level (The Scottish Index of Multiple Deprivation in Tayside), there 
was a pattern in both groups that, in the non-cataract group, patients were most likely 
to live in the both the most deprived and most affluent areas, while those in the 
middle categories were highest in the any cataract group.  
 
For biochemistry variables, total serum cholesterol, serum triglycerides and HbA1c 
were all higher in the any cataract group (4.02 vs. 3.89 mmol/L, 1.88 vs. 1.68 mmol/L, 
7.79 vs. 7.66 mg%). The high Albuminuria group (≥20 mg/L) had a higher percentage 
in the any cataract group than the non-cataract group (38.9% vs. 31.6%). 
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4. Results on Cataract Prevalence 
 
4.1. Prevalence of Diabetic Cataract and Age-adjusted Prevalence 
 
Table 15. Prevalence of diabetic cataract 
 Prevalence  Age-Adjusted 
Prevalence* 
Cataract n % 95% CI  % 95% CI 
Non-cataract 2026 61.8 60.1-63.5  76.0 74.5-77.5 
Any cataract 1253 38.2 36.5-39.9  24.0 22.5-25.5 
Total 3279 100   100  
*Age adjusted to population of Tayside, based on census of Scotland Health 
Board Area 2006 
 
Table 15 shows that the prevalence of diabetic cataract is 38.2% (1253/3279), and the 
age adjusted prevalence is down to 24.0%. Prevalence of each cataract subtype are not 
reported due to lack of data in the initial record. 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 Prevalence of diabetic cataract pie chart 
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4.2. Prevalence of Diabetic Cataract by Different Subgroups 
 
4.2.1. Diabetic Cataract Prevalence by Gender 
 
The prevalence of diabetic cataract for women was 40.8% and 36.0% for men (40.8% vs. 
36.0%, OR=0.818, 0.710-0.942 95% CI). The cross-tabulation result shows how any cataract 
and non-cataract individuals were distributed between different genders (Table 16). The 
Chi-square test revealed that the prevalence difference between female and male was 
statistically significant (P<0.05), and with OR=0.818, meaning that women had a lower 
chance of getting diabetic cataract than men.  
 
Table 16. Cross-tabulation result for gender and cataract 
  Female Male Total 
Any cataract 618 635 1253 
Non-cataract 898 1128 2026 
Total 1516 1763 3279 
 
Figure 11. Prevalence of diabetic cataract in different gender bar chart 
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Figure 11 is a bar chart that describes the prevalence of diabetic cataract in different gender. 
There were less female diabetic cataract patients in quantity but the prevalence of diabetic 
cataract was higher for women. 
 
 
4.2.2. Diabetic Cataract Prevalence by Age Group 
 
 
The cataract prevalence for each age groups varied with statistical significance (P<0.05). 90+ 
years group has the highest prevalence of cataract 71.9%. 80-90 years group and 70-80 years 
group share a similar case numbers while the elder group has significantly higher cataract 
prevalence (51.6% VS. 35.2%). From Figure 12, the prevalence of diabetic cataract grows 
with age groups, as growing age can be a strong indicator for having diabetic cataract. 
 
 
 
 
Table 17. Cataract and age group 
  
Age Group 
Total 40-50 
years 
50-60 
years 
60-70 
years 
70-80 
years 
80-90 
years 
90 years 
above 
Any cataract 11 40 98 367 540 197 1253 
Non-cataract 65 190 512 676 506 77 2026 
Total 76 230 610 1043 1046 274 3279 
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Figure 12. Prevalence of cataract in different age groups bar chart  
 
 
4.2.3. Diabetic Cataract Prevalence by BMI (Overweight) 
 
Table 18. Cataract prevalence by overweight status 
  
Over weight status  
Total 
Normal Weight Over Weight 
Any cataract 
303 950 1253 
47.2% 36.0% 38.2% 
Non-cataract 
339 1687 2026 
52.8% 64.0% 61.8% 
Total 
642 2637 3279 
100.0% 100.0% 100.0% 
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An overweight subject in this study was determined by BMI of above 25 kg/m^2. 
There are 642 normal weight subjects and 2637 overweight subjects; the overweight 
rate is as high as 80.4%. The prevalence of cataract was 47.2% in normal weight 
group. However, the prevalence in overweight group was 64.0%. In Chi-square Tests, 
the difference between two groups is significant (P<0.05) 
 
 
Figure 13. Prevalence of diabetic cataract by overweight or not bar chart 
 
 
 
 
 
 
 
 
 
52 
 
4.2.4. Diabetic Cataract Prevalence by Diabetes Duration 
 
 
Table 19. Cross-tabulation result for duration of diabetes and cataract 
  
Duration of diabetes 
Total Duration of 
diabetes, ≤10 years 
Duration of 
diabetes, >10 years 
Any cataract 93 1160 1253 
Non-cataract 94 1932 2026 
Total 187 3092 3279 
 
 
Although the percentage of diabetic cataract was higher for shorter duration (≤10 
years) of diabetes compared to longer diabetes history (>10 years), and the chi-square 
test revealed that the prevalence difference between diabetes duration subgroups was 
statistically significant (P<0.05), it is not ideal to use categorical variable to explore 
its relationship with cataract compared to numerical variable. By exploring diabetes 
duration (years), the OR for diabetes duration was 1.035 with 95% CI of 1.026-1.044, 
which meant increasing in risk with increasing duration of diabetes. 
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4.2.5. Diabetic Cataract Prevalence by Smoking Status 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Distribution of diabetic cataract by smoking status bar chart 
 
The results show that current smokers in the studied population have the lowest 
cataract prevalence (28.3%), and a non-smokers have the cataract prevalence of 38.2% 
and the ex-smokers have the highest cataract prevalence (42.0%). 
 
Table 20. Cataract prevalence by smoking status 
  
Smoking Status 
Total 
Unknown Current Smoker Ex-Smoker Never 
Any cataract 0 127 493 633 1253 
Non-cataract 2 321 680 1023 2026 
Total 2 448 1173 1656 3279 
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4.2.6. Diabetic Cataract Prevalence by Deprivation Level 
 
 
 
Figure 15. Distribution of diabetic cataract by deprivation level bar chart 
 
Table 21. Cataract prevalence by deprivation level 
  
Deprivation Level 
 
most 
deprived 
deprived middle affluent 
most 
affluent 
Total 
Any 
cataract 
319 279 214 203 238 1253 
30.5% 40.4% 47.5% 45.7% 36.7% 38.2% 
Non-catar
act 
727 411 237 241 410 2026 
69.5% 59.6% 52.5% 54.3% 63.3% 61.8% 
Total 
1046 690 451 444 648 3279 
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
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Subjects from the most deprived families have the lowest cataract prevalence (30.5%) 
while the middle have the highest cataract prevalence (47.5%) followed by affluent 
(45.7%), these two groups also have the lowest number of subjects in the dataset. The 
Chi-square test shows that the cataract prevalence difference between different 
deprivation level was statistically significant (P<0.05). 
 
 
 
5. Identification and Exploration of Diabetic Cataract Risk Factors 
 
 
There are many known risk factors for general cataract and senile cataract, while the 
exploration of risk factors and protect factors has few supporting literatures. Based on 
the review of general cataract, selected variables were included in the binary logistic 
regression model using enter mothed. 
 
 
Table 22. Risk factors for any cataract in diabetic subjects   
 Univariate Analysis  Multivariate Analysis 
 n(%) or 
 Mean ± SD 
Non-cataract 
(2026) 
n(%) or  
Mean ± SD 
Any Cataract 
(1253) 
OR (95% CI) P OR (95% CI) P 
Age, y 72.51±11.07 80.38±9.67 1.077(1.069-1.
086) 
<0.0001 1.080(1.070-1.
090) 
<0.0001 
Gender       
Women 898(44.3) 618(49.3)     
Men 1128(55.7) 635(50.7) 0.818(0.710-0.
942) 
0.005 0.816(0.689-0.
967) 
0.019 
56 
 
Duration of diabetes, y 19.04±7.24 21.47±9.84 1.035(1.026-1.
044) 
<0.0001 1.043(1.032-1.
053) 
<0.0001 
Smoking       
Non-smoker 1023(50.5) 633(50.5)     
Ex-smoker 680(33.6) 493(39.3) 1.172(1.006-1.
365) 
0.042 1.155(0.972-1.
372) 
0.102 
Current smoker 321(15.8) 127(10.1) 0.639(0.509-0.
803) 
<0.0001 0.934(0.722-1.
209) 
0.604 
BMI , kg/m2       
1st quintile <25.06 343(17.0) 308(24.6)     
2nd quintile 25.06-28.04 397(19.6) 259(20.7) 0.727(0.583-0.
905) 
0.004 0.851(0.666-1.
087) 
0.196 
3rd quintile 28.05-30.92 410(20.3) 245(19.6) 0.665(0.534-0.
830) 
<0.0001 0.842(0.655-1.
081) 
0.178 
4th quintile 30.93-34.88 427(21.1) 230(18.4) 0.600(0.480-0.
749) 
<0.0001 0.883(0.684-1.
139) 
0.337 
5th quintile >34.88 445(22.0) 210(16.8) 0.526(0.420-0.
658) 
<0.0001 1.023(0.781-1.
339) 
0.870 
Deprivation Level 
(Tayside)* 
      
Most deprived 727(35.9) 319(25.5)     
Deprived 411(20.3) 279(22.3) 1.547(1.265-1.
892) 
<0.0001 1.306(1.047-1.
629) 
0.018 
Middle 237(11.7) 214(17.1) 2.058(1.640-2.
582) 
<0.0001 1.897(1.477-2.
438) 
<0.0001 
Affluent 241(11.9) 203(16.2) 1.92(1.528-2.4
12) 
<0.0001 1.718(1.330-2.
219) 
<0.0001 
Most affluent 410(20.2) 238(19.0) 1.323(1.076-1.
627) 
0.008 1.071(0.851-1.
349) 
0.559 
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Blood pressure       
Diastole, mmHg 72.60±10.54 70.16±10.92 0.995(0.992-0.
999) 
0.017 1.000(0.992-1.
009) 
0.970 
Systole, mmHg 137.35±17.95 135.69±20.02 0.979(0.972-0.
985) 
<0.0001 0.991(0.986-0.
996) 
<0.0001 
Albuminuria       
<20 mg/L 1386(68.4) 766(61.1)     
≥20 mg/L 640(31.6) 487(38.9) 1.377(1.188-1.
595) 
<0.0001 1.273(1.077-1.
504) 
0.005 
Total serum 
Cholesterol, mmol/L 
      
1st quintile <3.16 363(17.9) 286(22.8)     
2nd quintile 3.16-3.66 402(19.8) 252(20.1) 0.796(0.638-0.
992) 
0.043 0.814(0.628-1.
054) 
0.119 
3rd quintile 3.67-4.11 410(20.2) 248(19.8) 0.768(0.615-0.
958) 
0.019 0.789(0.597-1.
044) 
0.097 
4th quintile 4.12-4.66 430(21.2) 229(18.3) 0.676(0.541-0.
845) 
0.001 0.650(0.479-0.
881) 
0.006 
5th quintile >4.66 421(20.8) 238(19.0) 0.718(0.575-0.
896) 
0.003 0.624(0.446-0.
874) 
0.006 
Serum triglycerides, 
mmol/L 
      
1st quintile <0.99 373(18.4) 284(22.7)     
2nd quintile 1.00-1.37 394(19.4) 263(21.0) 0.877(0.704-1.
092) 
0.240 0.913(0.711-1.
173) 
0.478 
3rd quintile 1.38-1.80 417(20.6) 242(19.3) 0.762(0.611-0.
951) 
0.016 0.808(0.625-1.
045) 
0.104 
4th quintile 1.81-2.44 410(20.2) 248(19.8) 0.794(0.637-0.
991) 
0.041 1.026(0.783-1.
345) 
0.852 
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5th quintile >2.44 432(21.3) 216(17.2) 0.657(0.525-0.
822) 
<0.0001 0.885(0.659-1.
190) 
0.419 
Serum HDL cholesterol, 
mmol/L 
      
1st quintile <0.95 410(20.2) 253(20.2)     
2nd quintile 0.95-1.13 444(21.9) 216(17.2) 0.788(0.629-0.
988) 
0.039 0.688(0.534-0.
886) 
0.004 
3rd quintile 1.14-1.30 395(19.5) 269(21.5) 1.104(0.885-1.
376) 
0.381 1.010(0.783-1.
303) 
0.939 
4th quintile 1.31-1.58 402(19.8) 250(20.0) 1.008(0.807-1.
259) 
0.945 0.857(0.655-1.
123) 
0.263 
5th quintile >1.58 375(18.5) 265(21.1) 1.145(1.917-1.
430) 
0.231 0.992(0.735-1.
339) 
0.959 
HBA1C, mg%       
1st quintile <6.5 443(21.9) 301(24.0)     
2nd quintile 6.6-7.1 391(19.3) 243(19.4) 0.915(0.736-1.
136) 
0.420 0.951(0.748-1.
208) 
0.679 
3rd quintile 7.2-7.8 413(20.4) 244(19.5) 0.870(0.701-1.
079) 
0.204 0.968(0.762-1.
231) 
0.793 
4th quintile 7.9-8.9 358(17.7) 243(19.4) 0.999(0.802-1.
244) 
0.993 1.153(0.897-1.
481) 
0.267 
5th quintile >8.9 421(20.8) 222(17.7) 0.776(0.624-0.
966) 
0.023 1.111(0.858-1.
439) 
0.423 
Serum LDL cholesterol, 
mmol/L 
      
1st quintile <1.31 405(20.0) 257(20.5)     
2nd quintile 1.32-1.67 406(20.0) 260(20.8) 1.009(0.809-1.
258) 
0.935 1.244(0.969-1.
599) 
0.087 
3rd quintile 1.68-2.02 410(20.2) 242(19.3) 0.930(0.744-1. 0.524 1.268(0.968-1. 0.084 
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162) 661) 
4th quintile 2.03-2.50 388(19.2) 257(20.5) 1.044(0.836-1.
162) 
0.705 1.440(1.085-1.
912) 
0.012 
5th quintile >2.50 417(20.6) 237(18.9) 0.896(0.716-1.
120) 
0.333 1.493(1.098-2.
030) 
0.011 
       
Significant results are shown in bold front (P<0.05). 
* Deprivation Level (Tayside) was the SIMD (Scottish index of multiple deprivation) score based on the relative ranking within 
Tayside from most deprived to least deprived. In this study, deprivation level includes “most deprived”, “deprived”, “middle”, 
“affluent”, “most affluent” five levels. 
 
 
Table 22 is a summary table which includes the results of both univariate analysis and 
multivariate analysis of all variables. The analysis was performed to identify risk 
factors and protective factors for diabetic cataract. In the initial univariate analysis, 
the risk factors were older age (OR=1.077, 95% CI, 1.069), being female (OR=1.222, 
95% CI, 1.061-1.408), longer duration of diabetes (OR=1.035, 95% CI, 1.026-1.044), 
being an ex-smoker (OR=1.172, 95% CI, 1.006-1.365) and being affluent (OR varied 
from 1.323 to 2,058). For biochemistry factors, albuminuria ≥20 mg/L (OR=1.377, 95% 
CI, 1.188-1.595) was the only identified risk factor, while other test results like higher 
total cholesterol (OR from 0.676 to 0.796), higher triglycerides (OR= 0.657 to 0.794) 
and higher HbA1c (5th quintile OR=0.776, 95% CI, 0.624-0.966) were protective 
factors. It is worth noting that higher blood pressure (both diastole and systole) was a 
protective factor (OR=0.995, 95% CI, 0.992-0.999/OR=0.979, 95% CI, 0.972-0.985). 
Higher BMI (OR from 0.526 to 0.727) and being a current smoker (OR= 0.639, 95% 
CI, 0.509-0.803) were also unexpected protective factors.  
 
In multivariate analysis, the risk factors for any cataract were older age (years, 
OR=1.080, 95% CI, 1.070-1.090), longer duration of diabetes (years, OR=1.033, 95% 
CI, 1.032-1.053) and being in an affluent family (OR, 1.306 for deprived group, 1.897 
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for middle, 1.718 for affluent group). For biochemistry factors, albuminuria ≥20mg/L 
(OR=1.273, 95% CI, 1.077-1.504) and higher serum LDL cholesterol (OR=1.440 for 
2.03-2.50 mmol/L, OR=1.493 for >2.50 mmol/L) were risk factors. For protective 
factors, being female (OR=0.816, 95% CI, 0.689-0.967), higher systolic blood 
pressure (OR=0.991, 95% CI, 0.986-0.996) and higher total serum cholesterol 
(OR=0.650 for 4.12-4.66 mmol/L, OR=0.624 for >4.66 mmol/L) were identified. 
 
 
6. Comparison of Risk Factors for Any Cataract in Gender and Diabetes Duration 
Subgroups 
 
 
The analysis for gender and duration of diabetes on risk factors of diabetic cataract 
were presented in Table 23. It is worth noticing that albuminuria ≥20mg/L and 
diastolic blood pressure (DBP) were no longer significant in the population with 
shorter duration of diabetes, but given the fact that cataract patients with less than 10 
years of diabetes is far less than those with longer diabetes duration (93 VS 1160), the 
I still consider albuminuria ≥20mg/L and lower DBP to be potential risk factors for 
diabetic cataract. HbA1c as a numeric variable was only significant in the female 
population as a protective factor.  
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Table 23. Differences in the risk factors for any cataract 
 Gender Duration of Diabetes 
 Men (635) Women (618) Shorter Duration 
(≤10 years) (93) 
Longer Duration 
(>10 years) (1160) 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Age 1.070(1.059-1.082) 1.084(1.072-1.097) 1.102(1.060-1.145) 1.077(1.068-1.086) 
Albuminuria ≥20 mg/L 1.409(1.154-1.720) 1.393(1.117-1.736) 1.383(0.774-2.472)* 1.362(1.169-1.586) 
Diastole blood pressure 
(mmHg) 
0.972(0.963-0.981) 0.986(0.977-0.996) 0.988(0.964-1.013)* 0.979(.0972-0.985) 
Total serum cholesterol 
(mmol/L) 
0.836(0.749-0.934) 0.869(0.784-0.964) 0.638(0.460-0.885) 0.898(0.832-0.969) 
HbA1C (mg%) 1.002(0.940-1.068)* 0.898(0.842-0.958) 0.861(0.696-1.065)* 0.960(0.917-1.006)* 
* P>0.05, not statistically significant. 
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7. Result on Postcode areas 
 
7.1. Geographical Distribution of Diabetic Cataract Cases 
 
 
 
Figure 16 shows the geographical distribution of diabetic cataract cases by postcode 
areas and the colour indicates the percentage of diabetic cataract case in each 
postcode area. Each blue dot represents one diabetic cataract cases, and from the map 
above, Dundee city had the most diabetic cataract cases but with lower percentage of 
cataract (number of cataract cases divided by whole population in the postcode area 
using 2006 census data) according to the light colour. In the city of Perth areas, the 
percentage of cataract is higher than Dundee city. 
 
For diabetic patients, living in rural areas may have a higher risk of cataract compared 
to living in large urban areas, for example Dundee city (DD2-DD5) had the lowest 
Figure 16. Geological distribution of diabetic cataract 
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percentage of diabetic cataract cases (lighter colour) whilst DD7, 8, 10 and 11 (other 
urban areas) had a higher percentage (darker colour). Some rural postcode areas had 
only a few cases and the variation in their prevalence was large and unsuited for 
reference. 
 
7.2. Diabetic Cases Percentage in Each Postcode Area 
 
 
 
 
 
Figure 17 shows the percentages of non-cataract and any cataract cases in each 
postcode area. 87.3% of non-cataract cases and 52.6% of any cataract cases were in 
Dundee city areas (DD2-DD5). 
 
 
 
 
 
 
Figure 17. Diabetic cases percentage in each postcode area 
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7.3. Result for Dundee City Areas 
 
 
Figure 18. Prevalence of diabetic cataract in Dundee postcode areas 
 
DD2 to DD5 postcode covers most areas of Dundee city from west to east. The 
prevalence of diabetic cataract for these postcode areas are showed in Figure 18. DD2 
has the highest cataract prevalence 29.3% but still much lower than the overall 
cataract prevalence of the whole studied population. DD5 has the lowest prevalence 
(18.4%) in Dundee city area, but the Chi-square test result for postcode area and 
cataract had P>0.05 which means the difference between postcode is not statistical 
significant. 
 
Then the following figures were created to reveal the distribution of deprivation status 
in different postcode areas. 
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Figure 19. Distribution of subjects’ deprivation level in Dundee postcode areas 
 
 
DD5 has the most affluent individuals, followed by DD2 area, DD3 and DD4 have 
more poor families. Chi-square test shows that the difference of deprivation level is 
statistically significant (P<0.05). From the deprivation level in DD2 area, both the 
most deprived and most affluent individuals are dominant in this area. It became 
obvious that the weakness of using postcode area is that area divided by the first three 
digits of postcode is too large when analysing an area of high population density with 
complex component. 
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8. Geographical Distribution of Diabetic Cataract Cases 
 
Table 24. Cataract related percentages 
 
Number of 
cases 
percentage in any 
cataract group 
Percentage in all 
cases 
Current any eye cataract  976 77.9% 29.8% 
  Current single eye cataract 701 55.9% 21.4% 
  Current both eye cataract 275 21.9% 8.4% 
Had any cataract extraction 277 22.1% 8.4% 
  Had only right eye extraction 58 4.6% 1.8% 
  Had only left eye extraction 150 12.0% 4.6% 
  Had both eye extraction 69 5.5% 2.1% 
 
 
 
71.8%
28.2%
Percentage for current 
cataract
current single eye cataract
current both eye cataract
20.9%
54.2%
24.9%
Percentage for cataract 
extraction 
had only right eye extraction
had only left eye extraction
had both eye extraction
Figure 20. Pie chart of percentage for cataract eye and 
cataract extraction 
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Table 24 shows the distribution of diabetic cataract-related characteristics. Among 
1,253 diabetic cataract cases, 55.9% (701/1253) of subjects currently had cataract in 
one eye and 21.9% (275/1,253) of subjects currently had cataract in both eyes, which 
was nearly one third of whole current cataract cases (28.2%, Figure 20). There were 
277 (22.1%) diabetes cataract cases who had already had cataract extraction, among 
which, more than half of patients had left eye cataract extraction only (54.2%, Figure 
20), 20.9% had right eye cataract extraction only (Figure 20) and a quarter of patients 
had extraction for both eyes (24.9%, Figure 20). 
 
 
 
 
 
 
 
 
 
 
 
 
The cross table for current cataract eyes shows that there are 10 cases with missing 
left eye data and unknown right eye data, and 4 cases with missing right eye data and 
unknown left eye data. With missing data and unknown status, the actual cataract and 
cataract surgery percentage for specific eye could not be known, the lack of detail in 
health record is one of the study dataset weakness. 
 
 
 
 
 
Table 25. Missing and unknown cataract eye cases 
  
Cataract Left Eye Case(N) 
Total 
Unknown Present Absent Missing 
Cataract 
Right Eye 
Cases(N) 
Unknown 0 28 0 10 38 
Present 34 275 75 227 611 
Absent 0 57 2026 0 2083 
Missing 4 315 0 228 547 
Total 38 675 2101 465 3279 
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Discussion  
 
1. Discussion of the result 
 
The purpose of this study was to explore the current diabetic cataract status in a 
certain health board area in Scotland (Tayside), using electronic health record linkage 
data, thus presenting an epidemiological report of cataract in a diabetic population 
over 40 years of age. Basic demographic variables, biochemical test results and 
medical results were all analyzed at different level. Risk factors and protective factors 
for diabetic cataract were also identified using regression models. The key finding of 
the study is that cataract (including who had cataract extraction) prevalence in a 
defined diabetic population is 38.2% (Table 15), and percentage of current cataract in 
this study is 29.8% (Table 24).  
 
The prevalence data for different subgroups in this study (a diabetic population) were 
partially consistent with previous cataract studies’ findings. In this study, I found that 
the prevalence of cataract in women was 40.8% compared with 36.0% of men. 
Similarly, previous studies for cataract prevalence in the United States and Australian 
populations reported that women had higher cataract prevalence and risk than men. 
25,63  
 
Another result in this study showed that subjects who have had diabetes for less than 
10 years had lower risk than patients with a diabetes history of over 10 years, which 
means that diabetic patients are more likely to develop cataracts with increasing 
diabetes duration. This result corresponded to previous findings in others studies 
where longer duration of diabetes was a significant risk factor for cataract and so the 
incidence of cataract would be expected to increase with longer duration of diabetes. 
64 Furthermore, The Blue Mountains Eye Study 2-year follow-up found that diabetic 
patients with longer than 10 years’ disease duration had a higher risk (RR=3.3) of 
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developing cataracts in the future. 65  
 
In Table 22, the multivariate analysis offered eight identified variables as risk or 
protective factors for diabetic cataract. We found that age and duration of diabetes 
were two strong non-modifiable risk factors. The main explanation is that lens 
proteins denature and degrade over time, and this process is accelerated by diseases 
such as diabetes. 65,66 We also noticed that the female gender tended to confer a 
protective effect (OR=0.846), however, females were proved to have a higher 
incidence of cataract than males by previous cataract studies. 67,68  
 
There was no clear cut for diagnostic criteria of hypertension in terms of blood 
pressure and thus the only cardiovascular related variable in this study was blood 
pressure number (diastolic and systolic). Based on a previous prospective study of 
blood pressure and risk of cataract, there was no strong association between cataract 
and blood pressure, which is subject to confounding by multiple risk factors. 69 
However, recent findings suggest that cataract and systolic blood pressure were 
significantly associated but not associated for diastolic blood pressure. 70 According to 
the results, higher systolic blood pressure was a protective factor (OR=0.991), which 
would decrease 9.0% of risk when systolic blood pressure rose by 10 mmHg.  
 
For biochemistry test variables, higher urine albuminuria (≥20mg/L) was a risk factor 
(OR=1.273), which can occur in patients with long-standing diabetes. 71 Findings 
from varied studies suggested that albuminuria predicted renal failure over the short 
and intermediate term. 72,73,74 As one of the severest complication of albuminuria, 
renal failure was identified as risk factor of cataract in a case-control study of cataract 
by Oxford University. 75  
 
In varied epidemiological studies, it has been suggested that in different contexts, 
cholesterol may act as an antioxidant in the lens. 76,77 Higher serum LDL cholesterol is 
another risk factor in this study (OR=1.440 for 2.03-2.50 mmol/L, OR=1.493 
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for >2.50 mmol/L), while results also showed higher total serum cholesterol to be a 
protective element (OR=0.650 for 4.12-4.66 mmol/L, OR=0.624 for >4.66 mmol/L). 
Previous study supported that High LDL cholesterol was a significant cataract risk 
factor. 78 The lens is supposed to be protected by the high HDL cholesterol, the low 
LDL: HDL ratio also could decrease the risk of cataract in patients. 79 However, no 
evidence was found that serum HDL cholesterol was significantly associated with the 
development of cataract.  
 
We also included deprivation factors in the regression model that highlighted some 
interesting results. The SIMD score was introduced to measure deprivation level and 
it incorporated seven different aspects (employment; income; health, education, skills, 
and training; geographic access to services; crime; housing) of deprivation, combining 
them into a single index. SIMD score was based on ranking within a certain area. The 
SIMD scores we used were within the Tayside health board area. Previous studies 
have reported that more deprived populations have a higher risk of developing 
cataract. 80 Reports from the WHO Commission on Social Determinants of Health 
have emphasized the link between social and health inequalities. Lower 
socioeconomic status (SES) has been shown to be associated with a higher risk of eye 
health. 81,82 Affluent families are able to have access to better healthcare to help 
prevent cataracts from developing and they can even have cataract surgery at an early 
state of disease, which could reduce the prevalence of cataract. 82 In this study, being 
in a more affluent family than the most deprived ones increased the risk of cataract 
(OR, 1.306 for deprived group, 1.897 for middle, 1.718 for affluent group). The 
possible explanation could be that wealthier people in the Tayside area have a higher 
chance of being outside during leisure time and have higher UV light exposure. 
Another possible factor could be that the Tayside area includes some of the sunniest 
places in Scotland where the average is about 1,500 hours per year, which is more 
than the average in any other places (max 1,300 hours per year) in Scotland. 83 
Consequently, people in the sunniest places tend to protect themselves from being 
exposed in the strong UV light damage that is recognized as a potential risk factor of 
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cataract. But as the limitation of using electronic records, the dataset from my study 
doesn’t have information about UV exposure, so the real influence of sunshine 
exposure in the studied population remains to be further explored in the future. There 
is another reason related to accessibility, study showed that people with higher income 
were more likely to have eye screening services, 84 which may lead to a higher chance 
of being diagnosed with cataract. More studies are needed to explain why being 
affluent in the Tayside area is a risk factor for diabetic cataract.  
 
The geological distribution of diabetic cataract cases was also presented in my 
analysis (Figure 16). Compared to living in city areas, living in rural places may lead 
to increased risk of cataract. On the one hand, people in large urban areas are more 
likely to have easy access to the healthcare system that offers some protection in 
disease. They are also more likely to have the resources and knowledge in cataract 
prevention. 85 On the other hand, though the cases in rural areas were fewer, large 
variation in the data existed. Residents in rural areas experienced higher risk of 
cataract and rural communities may have lower access to optometrists and other 
optical health tests. 86 The reason why the geological factor was not thoroughly 
analyzed was that the geological information was the first half of the postcode, which 
covered a relatively large area for each postcode area (e.g. area DD8, DD9). The 
deprivation level distribution in Dundee city area in Figure 19 showed that both the 
wealthiest and the poorest lived in DD2 area, which may hinder the representativeness 
of geological variable.  
 
For the studied population, 29.8% of diabetic patients currently had cataracts in either 
eye. This included patients with single eye cataract (21.4%) and both eye cataract 
(8.4%) (Table 24). This is similar to previous reports that single eye cataract was 
worse than both eye, however, most people will eventually develop a cataract in both 
eyes, though one eye may be affected before the other. 87 Therefore, we could predict 
that the majority of patients with cataract are still in the process of cataract 
development. We also calculated the cataract extraction prevalence among studied 
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cases in Tayside (8.4%). Over the past decade, cataract surgical rates have doubled in 
most of UK. The current surgical rate approximates to a crude rate of 6.2 extractions 
per 1,000 populations. 87 The comparison with my results will show a consistent 
condition for surgery rate, because the surgery may be the only effective treatment for 
cataract for now. 87 
 
2. Contribution of the study 
 
The key contribution of this study is presenting an update on current cataract 
epidemiological status by analyzing existing electronic health records. The major 
figures and trends are consistent with previous studies in sources of population-based 
data for the prevalence of cataract in the UK. The prevalence of visually impairing 
cataract rose steadily with age, especially 24.0% in people of 70 to 74 years of age 
compared with 35.2% in the people of 70 to 80 years old (Table 17). 29,88-91 The 
identification of several potential risk and protective factors for diabetic cataract can 
provide reference for future studies.  
 
3. Shortcoming and limitation 
 
One obvious shortcoming in this study was over exclusion of cases. To be more 
specific, I excluded diabetes cases with incomplete cataract information during data 
processing with a strict rule, any incompletion of information can lead to exclusion 
and the strict exclusion may lead to potential bias.  
 
For instance, in the actual health record, according to previous findings concerning 
cataract duration, patients with shorter diabetes history were less likely to develop 
cataract and those who had no cataract tended to have incomplete cataract records 
(thus being excluded in the study). As a result, the number of non-cataract cases with 
shorter diabetes duration was likely underestimated in this study and the actual 
prevalence of cataract with less than 10 years’ cataract history could be lower, and the 
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risk of longer diabetes duration can be underestimated. In previous studies, higher risk 
of cataract for the shorter diabetes duration patients may be expected if the association 
is attributable to the effects of poor vision because the level of VI would be better 
reflected by a recent eye examination than one performed years ago.  
 
The major limitation of this study was the inability to subtype the cataract groups, 
which might invalidate some causal relationship between risk factor and cataracts or 
fail to identify potential risk factors. The other limitation is the lack of detail in 
cataract, cataract surgery and other medical record. Participants with healthy eyes 
have higher chance of being removed during data collection process. Address 
information is also limited to a vague postcode area which may hinder the research 
value from geographic perspective. 
 
Another limitation was that since this is a cross-sectional study about a relatively 
chronic disease, the incidence of diabetic cataract can’t be properly calculated. And as 
a result, all risk values were measured in OR rather than RR, which made it difficult 
to interpreted directly. 
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